Company: SCLXW
Filing Date: 2025-05-14
Form Type: 424B3
Source: 0001193125-25-119831
Chunk: 89

Company: Scilex Holding Co
Filing Date: 2025-05-14
Form: 424B3
Chunk 89
---
 do not commence or continue within specified periods agreed to by the parties; or
(e) in the event of our bankruptcy or assignment for the benefit of creditors. If the Romeg License Agreement is terminated for

55

certain reasons, such as our material breach of the agreement, our bankruptcy, or our failure to timely pay milestone payments, we will be required upon Romeg’s request to transfer all licensed intellectual property rights, including those relating to GLOPERBA and the Licensed Products, to Romeg or its designee, within thirty days after the termination of the Romeg License Agreement at a price to be agreed upon by the parties. The loss of such licenses could materially harm our business, financial condition and results of operations. Potential disputes over intellectual property rights that we have licensed may prevent or impair our ability to maintain our current licensing arrangements on acceptable terms. Licensing of intellectual property rights is of high importance to our business and involves complex legal, business and scientific issues. Disputes may arise between us and our licensors regarding intellectual property rights subject to a license agreement, including:

| • |     | the scope of rights granted under the license agreement and other interpretation-related issues; |

| • |     | our financial or other obligations under the license agreement; |

| • |     | whether and the extent to which our technology and processes infringe on intellectual property rights of the 
 licensor that are not subject to the licensing agreement;                                                    |

| • |     | our right to sublicense intellectual property rights to third parties under collaborative development 
 relationships;                                                                                        |

| • |     | our diligence obligations with respect to the use of the licensed technology in relation to our development and 
 commercialization of our product candidates, and what activities satisfy those diligence obligations; and       |

| • |     | the ownership of inventions and know-how resulting from the joint                  
 creation or use of intellectual property by our licensors and us and our partners. |

If disputes over intellectual property rights that we have licensed prevent or impair our ability to maintain our current licensing arrangements on acceptable terms, our business, financial condition and results of operations may be adversely affected. We may enter into additional licenses in the future and if we fail to comply with obligations under those agreements, we could suffer adverse consequences. Furthermore, if our licenses are terminated, or if the underlying patents fail to provide the intended exclusivity, competitors or other third parties would have the freedom to seek regulatory approval of, and to market, products identical or competitive to ours and we may be required to cease our development and